TIPE2 is encoded by TNFAIP8L2 and has been identified as a potential checkpoint molecule for NK cells maturation and anti-tumor immunity [26] and so targeting TIPE2 may be a potentially novel NK cell-based immunotherapy approach [3]. The gene discussed is TIPE2; the disease is neoplasm.